News tagged with biopharmaceutical company
New tuberculosis drug trial begins in South Africa
Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug ...
Diseases, Conditions, Syndromes
Dec 11, 2012 |
not rated yet |
0
New animal models can revolutionize the study of cancer
Some animal models developed by researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Catalan Institute of Oncology (ICO) has served to validate the effectiveness of a new drug ...
Cancer
Oct 09, 2012 |
not rated yet |
0
IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: ...
Medications
Aug 16, 2012 |
not rated yet |
0
New drug extends survival in patients with drug-resistant prostate cancer
A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression ...
Cancer
Feb 01, 2012 |
5 / 5 (1) |
0
|
UCF patented on induced pluripotent stem cells, iPS cells
A process that prompts a single gene to generate millions of supercharged stem cells, which can then turn into any kind of cell a body needs to repair itself, has been patented at the University of Central ...
Medical research
Dec 22, 2011 |
5 / 5 (1) |
0
Permeon reveals discovery of Intraphilins as new approach to intracellular biologic drugs
Permeon Biologics, a biopharmaceutical company pioneering a novel class of intracellular protein biologics, today announced the discovery of an entirely new class of naturally occurring human supercharged proteins called ...
Medications
Jul 28, 2011 |
5 / 5 (1) |
0
|
